Selecting analytical biomarkers for diagnostic applications: a first principles approach

References

• Atkinson A.J., Colburn, W.A., DeGruttola, V.G., et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89–95.
   PubMed Web of Science ®Google Scholar
• EPT do-it-yourself early-pregnancy test. Med Lett Drugs Ther. 1978;20(8):30–40.
   PubMed Web of Science ®Google Scholar
• Zhao X, Modur V, Carayannopoulos LN, et al. Biomarkers in pharmaceutical research. Clin Chem. 2015;61(11):1343–1353.
   PubMed Web of Science ®Google Scholar
• Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2011;5(6):463–466.
   Web of Science ®Google Scholar
• Derda R, Gitaka J, Klapperich CM, et al. Enabling the development and deployment of next generation point-of-care diagnostics. PLoS Negl Trop Dis. 2015;9(5):1–16.
   Web of Science ®Google Scholar
• Vashist SK, Luppa PB, Yeo LY, et al. Emerging technologies for next-generation point-of-care testing. Trends Biotechnol. 2015; 33(11): 692–705 .
   PubMed Web of Science ®Google Scholar
• Kumar AA, Hennek JW, Smith BS, et al. From the bench to the field in low-cost diagnostics: two case studies. Angew Chemie Int Ed. 2015;54(20):5836–5853.
   PubMed Web of Science ®Google Scholar
• Dondorp AM, Desakorn V, Pongtavornpinyo W, et al. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2005;2(8):0788–0797.
   Web of Science ®Google Scholar
• Rogier E, Plucinski M, Lucchi N, et al. Bead-based immunoassay allows sub-picogram detection of histidine-rich protein 2 from Plasmodium falciparum and estimates reliability of malaria rapid diagnostic tests. PLoS One. 2017;12(2):e0172139.
   PubMed Web of Science ®Google Scholar
• Ramutton T, Hendrisksen ICE, Mwanga-Amumpaire J, et al. Sequence variation does not confound the measurement of plasma PfHRP2 concentration in African children presenting with severe malaria. Malar J. 2012;11(1):276.
   PubMed Web of Science ®Google Scholar
• Tran TM, Aghili A, Li S, et al. A nested real-time PCR assay for the quantification of Plasmodium falciparum DNA extracted from dried blood spots. Malar J. 2014;13:393.
   PubMed Web of Science ®Google Scholar
• Wihokhoen B, Dondorp AM, Turner P, et al. Use of blood smears and dried blood spots for polymerase chain reaction-based detection and quantification of bacterial infection and Plasmodium falciparum in severely ill febrile African children. Am J Trop Med Hyg. 2016;94(2):322–326.
   PubMed Web of Science ®Google Scholar
• Oyola SO, Ariani CV, Hamilton WL, et al. Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification. Malar J. 2016;15:597.
   PubMed Web of Science ®Google Scholar
• Laban NM, Kobayashi T, Hamapumbu H, et al. Comparison of a PfHRP2-based rapid diagnostic test and PCR for malaria in a low prevalence setting in rural southern Zambia: implications for elimination. Malar J. 2015;14:25.
   PubMed Web of Science ®Google Scholar
• Dobano C, Quelhas D, Quinto L, et al. Age-dependent igg subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children. Clin Vaccine Immunol. 2012;19(2):157–166.
   PubMed Web of Science ®Google Scholar
• Long GW, Fries L, Wall GH, et al. Polymerase chain reaction amplification from Plasmodium falciparum on dried blood spots. Am J Trop Med Hyg. 1995;52(4):344–346.
   PubMed Web of Science ®Google Scholar
• Ahmed Ismail H, Tijani MK, Langer C, et al. Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria. Malar J. 2014;13(1):425.
   PubMed Web of Science ®Google Scholar
• Duah NO, Miles DJC, Whittle HC, et al. Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort. Parasite Immunol. 2010;32(2):125–134.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Hu HG, Hou L. Discover, develop & validate–advance and prospect of tumor biomarkers. Clin Lab. 2015;61(11):1589–1599.
   PubMed Web of Science ®Google Scholar
• Sherin K, Klekamp BG, Beal J, et al. What is new in HIV infection? Am Fam Physician. 2014;89(4):265–272.
   PubMed Web of Science ®Google Scholar
• Fung ET. A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance. Clin Chem. 2010;56(2):327–329.
   PubMed Web of Science ®Google Scholar
• Bolad A, Farouk SE, Israelsson E, et al. Distinct interethnic differences in immunoglobulin G class/subclass and immunoglobulin M antibody responses to malaria antigens but not in immunoglobulin G responses to nonmalarial antigens in sympatric tribes living in West Africa. Scand J Immunol. 2005;61(4):380–386.
   PubMed Web of Science ®Google Scholar
• Farrar D, Fairley L, Wright J, et al. Evaluation of the impact of universal testing for gestational diabetes mellitus on maternal and neonatal health outcomes: a retrospective analysis. BMC Pregnancy Childbirth. 2014;14(1):317.
   PubMed Web of Science ®Google Scholar
• Diclemente RJ, Wingood GM, Harrington KF, et al. Efficacy of an HIV prevention intervention. Journal of the American Medical Association. 2004;292(2):171–179.
   Google Scholar
• Van Der Meide PH, Schellekens H. Cytokines and the immune response. Biotherapy. 1996;8(3–4):243–249.
   PubMedGoogle Scholar
• The Mayo Clinic C. Eosinophilia. Mayo Foundation for Medical Education and Research. 2017. p. 1–3.
   Google Scholar
• Luna Coronell JA, Syed P, Sergelen K, et al. The current status of cancer biomarker research using tumour-associated antigens for minimal invasive and early cancer diagnostics. J Proteomics. 2012;76:102–115.
   PubMed Web of Science ®Google Scholar
• Ray S, Patel SK, Kumar V, et al. Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures. Proteomics Clin Appl. 2014;8(1–2):53–72.
   PubMed Web of Science ®Google Scholar
• Wenk MR. Lipidomics in drug and biomarker development. Expert Opin Drug Discov. 2006;1(7):723–736.
   PubMed Web of Science ®Google Scholar
• Størling J, Pociot F. Type 1 diabetes candidate genes linked to pancreatic islet cell inflammation and beta-cell apoptosis. Genes (Basel). 2017;8(2):72.
   Web of Science ®Google Scholar
• Higgins T. HbA1c for screening and diagnosis of diabetes mellitus. Endocrine. 2013;43(2):266–273.
   PubMed Web of Science ®Google Scholar
• Loubiere S, Moatti J-P. Economic evaluation of point-of-care diagnostic technologies for infectious diseases. Clin Microbiol Infect. 2010 Aug;16(8):1070–1076.
   PubMed Web of Science ®Google Scholar
• Losina E, Weinstein MC, Anglaret X, et al. Cost-effectiveness of HIV treatment in resource-poor settings — the case of Côte d’Ivoire. The New England Journal of Medicine. 2006: p. 1141–1153.
   Google Scholar
• Weigl BH, Boyle DS, de los Santos T, et al. Simplicity of use: a critical feature for widespread adoption of diagnostic technologies in low-resource settings. Expert Rev Med Devices. 2009;6(5):461–464.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Snyder G, Ressler D. The current and future state of companion diagnostics. Pharmgenomics Pers Med. 2015;8:99.
   PubMed Web of Science ®Google Scholar
• Ely S. Personalized medicine: individualized care of cancer patients. J Lab Clin Med. 2009;154(6):303–308.
   Google Scholar
• Goulart LR, Vieira CU, Freschi APP, et al. Biomarkers for serum diagnosis of infectious diseases and their potential application in novel senor platforms. Crit Rev Immunol. 2010;30(2):201–222.
   PubMed Web of Science ®Google Scholar
• Thompson M, Weigl B, Fitzpatrick A, et al. More than just accuracy: a novel method to incorporate multiple test attributes in evaluating diagnostic tests including point of care tests. IEEE J Transl Eng Heal Med. 2016 Apr;4.
   PubMedGoogle Scholar
• Sugunendran H, Birley HDL, Mallinson H, et al. Comparison of urine, first and second endourethral swabs for PCR based detection of genital Chlamydia trachomatis infection in male patients. Sex Transm Dis. 2001;77:423–426.
   Web of Science ®Google Scholar
• Cook RL, Hutchison SL, Braithwaite RS, et al. Review systematic review: noninvasive testing for Chlamydia trachomatis. Ann Intern Med. 2005;142:914–925.
   PubMed Web of Science ®Google Scholar
• Chernesky M, Jang D, Chong S, et al. Impact of urine collection order on the ability of assays to identify Chlamydia trachomatis infections in men. Sex Transm Dis. 2003;30(4):345–347.
   PubMed Web of Science ®Google Scholar
• Michel C-EC, Sonnex C, Carne CA, et al. Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies. J Clin Microbiol. 2007 May;45(5):1395–1402.
   PubMed Web of Science ®Google Scholar
• Peeling RW, Smith PG, Bossuyt PMM. A guide for diagnostic evaluations. Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S2–6.
   PubMedGoogle Scholar
• De La Cruz-Hernández SI, Flores-Aguilar H, Gonzalez-Mateos S, et al. Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico. Am J Trop Med Hyg. 2013;88(3):446–454.
   PubMed Web of Science ®Google Scholar
• Leligdowicz A, Conroy AL, Hawkes M, et al. Validation of two multiplex platforms to quantify circulating markers of inflammation and endothelial injury in severe infection. PLoS One. 2017;12(4):1–14.
   Web of Science ®Google Scholar
• Conroy AL, Hawkes M, McDonald CR, et al. Host biomarkers are associated with response to therapy and long-term mortality in pediatric severe malaria. Infect Dis Soc Am. 2016;3(3):1–10.
   Google Scholar
• Kreutz JE, Munson T, Huynh T, et al. Multiplexed quantification of nucleic acids with large dynamic range using multivolume digital RT-PCR on a rotational SlipChip tested with HIV and hepatitis C viral load. Anal Chem. 2011;83:8158–8168.
   PubMed Web of Science ®Google Scholar
• ThermoFisher Scientific, “Digital PCR.” [Online]. Accessed October 2017. Available from: https://www.thermofisher.com/us/en/home/life-science/pcr/digital-pcr.html.
   Google Scholar
• Simon S, Ezan E. Ultrasensitive bioanalysis: current status and future trends. Bioanalysis. 2017;9:753–764.
   PubMed Web of Science ®Google Scholar
• Yeung D, Ciotti S, Purushothama S, et al. Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum. J Immunol Methods. 2016;437:53–63.
   PubMed Web of Science ®Google Scholar
• Fischer SK, Joyce A, Spengler M, et al. Emerging technologies to increase ligand binding assay sensitivity. Aaps J. 2015;17(1):93–101.
   PubMed Web of Science ®Google Scholar
• Cowan KJ, Geiger A, Hornauer H, et al. Performance evaluation of three platforms with ultrasensitive ligand-binding assay potential. Bioanalysis. 2017;9:937–946.
   PubMed Web of Science ®Google Scholar
• Collet-Brose J, Couble P, Deehan MR, et al. Evaluation of multiple immunoassay technology platforms to select the anti-drug antibody assay exhibiting the most appropriate drug and target tolerance. J Immunol Res. 2016;2016.
   PubMed Web of Science ®Google Scholar
• Semiglazov VF, Semiglazov VV, Dashyan GA, et al. Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer. Cancer. 2007;110(2):244–254.
   PubMed Web of Science ®Google Scholar
• Limper M, De Kruif MD, Duits AJ, et al. The diagnostic role of Procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect. 2010;60(6):409–416.
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec;380(9859):2095–2128.
   PubMed Web of Science ®Google Scholar